Cite Filings / LTRN / 0001493152-26-023740
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

Lantern Pharma Inc. · Filed 2026-05-15 · Acc 0001493152-26-023740

Documents 1

  • 10-Q Quarterly Report , form10-q.htm

Around this filing

  • 2026-08-14 10-Q Quarterly Report
  • 2026-05-15 SCHEDULE 13D/A Beneficial Ownership Report
  • 2026-05-15 8-K Results of operations
  • 2026-05-15 10-Q Quarterly Report
  • 2026-05-14 8-K Material agreement · Unregistered share sale · Other events
  • 2026-05-14 4 Director bought 48,544 shares at $2.06 ($100,001)
  • 2025-11-12 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading form10-q.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…